Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed Mar 10, 2016 · 10-K · 70 days after period end · 0001564590-16-014403
| Metric | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|
| Revenue | — | $0.00 | $6.00K |
| Net Income | -$10.72M | -$7.47M | -$3.48M |
| EPS Diluted | -$0.39 | -$0.37 | -$4.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 10, 2016 · 70 d after period end
